Accretion Nutraveda IPO Listing

Accretion Nutraveda IPO listing gain is [.]% on BSE; the stock opened at ₹[.]. The IPO GMP was ₹4 last heard.
Accretion Nutraveda IPO

Table of Contents

Accretion Nutraveda IPO was subscribed 1.83 times on the last day, a retail quota was subscribed over 2.19 times, NII subscribed over 2.08 times, and QIB was subscribed 1.01 times, respectively. 

Accretion Nutraveda IPO Listing Details

Find the Accretion Nutraveda IPO listing details like BSE Code, NSE Code, ISIN Number, and Listing Group below:

Listing DateFebruary 4, 2026
BSE Code
NSE Code
ISIN No
Offer Price₹122 to ₹129
Face Value₹10
Listing Price₹[.]

Details About Accretion Nutraveda IPO 

Accretion Nutraveda IPO received approval from SEBI for an IPO worth ₹24.77 crores via a fresh issue. Further, Accretion Nutraveda IPO had a set price band between ₹122 to ₹129 Per Share. 

Accretion Nutraveda IPO consists of 2,000 shares in 2 lot sizes for retail minimum and maximum categories as well. 

S-HNI minimum category consist 3000 shares, 3 lot sizes, and a maximum of 7,000 shares in the 7 lot sizes. B-HNI Minimum consist 8000 shares in 8 lot sizes. 

To invest in the Accretion Nutraveda IPO, each investor category has specific investment amounts: 

  • Retail Investors: minimum and maximum investment of ₹2,58,000.  
  • SHNI (S-HNI): Minimum investment of ₹3,87,000.
  • S-HNI maximum investment of: ₹9,03,000. 
  • B-HNI minimum investment of ₹10,32,000.

Accretion Nutraveda IPO Dates

Accretion Nutraveda IPO opened on January 28, 2026, and closed on January 30, 2026. Accretion Nutraveda IPO allotment date was scheduled on February 2, 2026. Accretion Nutraveda IPO listing date is January 4, 2026. 

Accretion Nutraveda IPO funds deployment 

  • A portion of the funds will be used for the purchase of machinery for Automation in the existing Manufacturing unit.
  • Some funds will be utilized towards the machinery for the new manufacturing setup
  • A portion of the fund will be used towards the working capital requirement of the company.
  • Lastly, the remaining funds will be used for the General Corporate Purpose.

About Accretion Nutraveda IPO Company 

Founded in 2021, Accretion Nutraveda is one of the leading companies involved in the manufacturing of Ayurvedic and Nutraceutical products in India. They offer various ayurvedic and nutraceutical products in various forms such as tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels. 

They combine science and Ayurveda to provide healthcare to treat many areas, such as liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness. The company runs a 10,763 sq. ft. manufacturing facility situated in Gujarat. The company serves its customers in India as well as in international countries like Sri Lanka, Singapore, and the USA.

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *